CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
35 hedge funds and large institutions have $29.3M invested in Cellular Biomedicine Group, Inc. in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
35
Holding in Top 10
–
Calls
–
Puts
$3K
Top Buyers
| 1 | +$424K | |
| 2 | +$258K | |
| 3 | +$170K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$125K |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
+$110K |
Top Sellers
| 1 | -$226K | |
| 2 | -$217K | |
| 3 | -$188K | |
| 4 |
Barclays
London,
United Kingdom
|
-$79K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$39.1K |